Capital Advisors Wealth Management’s Gilead Sciences GILD Stock Holding History

Capital Advisors Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$542K	Buy	3,635 +249	+7%	+$34.9K	0.06%	137
2026 Q2	$428K	Buy	3,386 +147	+5%	+$19.4K	0.05%	153
2026 Q1	$451K	Buy	3,239 +15	+0.5%	+$2.1K	0.06%	139
2025 Q4	$396K	Buy	3,224 +15	+0.5%	+$1.82K	0.05%	144
2025 Q3	$356K	Buy	3,209 +30	+0.9%	+$3.41K	0.05%	151
2025 Q2	$352K	Buy	3,179 +17	+0.5%	+$1.81K	0.06%	141
2025 Q1	$354K	Buy	3,162 +298	+10%	+$30.7K	0.06%	126
2024 Q4	$265K	Buy	2,864 +320	+13%	+$28.8K	0.05%	144
2024 Q3	$213K	Buy	+2,544	New	+$194K	0.04%	161

Other funds holding GILD

CIM

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

FFBTD

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

SCA

Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Capital Advisors Wealth Management's GILD Position: Q3 2026 in Review

Capital Advisors Wealth Management increased its Gilead Sciences (GILD) stake by 7.4% in Q3 2026, buying an estimated $34.9K and bringing the position to 3,635 shares worth $542K. The position accounts for 0.06% of the portfolio, ranked #137.

Capital Advisors Wealth Management first reported a position in GILD in Q3 2024 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Capital Advisors Wealth Management held 3,635 shares of Gilead Sciences worth $542K as of Q3 2026.
Capital Advisors Wealth Management bought 249 Gilead Sciences shares in Q3 2026, an estimated $34.9K.
Gilead Sciences made up 0.06% of Capital Advisors Wealth Management's portfolio in Q3 2026, its #137 holding.
Capital Advisors Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 9 quarters since.
119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Capital Advisors Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.